Skip to main content

Table 2 Summary of expression-validated genes (EVGs) from predicted transcripts over the entire human genome

From: A comprehensive transcript index of the human genome generated using microarrays and computational approaches

Gene categories

Sanger/PTI chromosome 20

Non-Sanger PTI chromosome 20

Sanger/PTI chromosome 22

Non-Sanger PTI chromosome 22

PTI genome-wide

Total Sanger genes represented

1,177 (826)

 

854 (575)

  

RefSeq

676 (552)

8 (2)

375 (290)

12 (5)

10,720 (7992)

Ab initio + expressed sequence + protein

336 (229)

10 (2)

285 (202)

10 (5)

8,801 (4269)

Ab initio + expressed sequence

38 (17)

96 (8)

28 (15)

74 (8)

3,733 (784)

Ab initio + protein

28 (9)

37 (7)

31 (16)

29 (4)

1,983 (233)

Expressed sequence + protein

38 (2)

37 (2)

36 (10)

24 (4)

1,126 (271)

Expressed sequence

22 (3)

1,591 (44)

31 (3)

1,127 (33)

7,170 (1428)

Ab initio

22 (12)

674 (39)

50 (35)

362 (17)

16,822 (555)

Protein

17 (2)

157 (7)

18 (4)

121 (4)

540 (110)

High-confidence categories

1,116 (809)

188 (21)

755 (533)

149 (26)

26,363 (13,549)

All categories

1,177 (826)

2,610 (111)

854 (575)

1,759 (80)

50,895 (15,642)

  1. Columns 1 and 3 provide the total number of Sanger genes for each category for chromosomes 20 and 22, respectively, with the number of EVGs detected given in parentheses. Columns 2 and 4 provide the total number of LPs that did not overlap Sanger genes, with the number of EVGs detected given in parentheses. The last column provides the total number of LPs in the PTI represented on the PTA microarrays, with the number of EVGs detected over the entire genome given in parentheses.